cytomegalovirus

cytomegalovirus
Name	Cytomegalovirus
Taxon	Cytomegalovirus
Subdivision ranks	Species
Subdivision	*Human betaherpesvirus 5

Cytomegalovirus is a ubiquitous herpesvirus belonging to the Betaherpesvirinae subfamily. It is a significant human pathogen, particularly for immunocompromised individuals and developing fetuses. The virus establishes lifelong latency following primary infection and can reactivate under conditions of immunosuppression.

Virology and classification

Cytomegalovirus is classified within the genus *Cytomegalovirus* of the subfamily Betaherpesvirinae in the family Herpesviridae. Its genome consists of a linear double-stranded DNA molecule, one of the largest among human viruses, encoding over 200 open reading frames. The virion is enveloped and contains an icosahedral nucleocapsid surrounded by a proteinaceous tegument. Key viral proteins include the major capsid protein and the glycoprotein B complex, which is critical for cell entry. Research on its replication cycle has been advanced through studies at institutions like the National Institutes of Health and the University of Alabama at Birmingham.

Pathogenesis and transmission

Primary infection typically occurs through contact with infected bodily fluids such as saliva, urine, breast milk, semen, and cervical secretions, or via blood transfusion and organ transplantation. The virus replicates in epithelial cells and fibroblasts, disseminating via leukocytes to establish latency primarily in CD34+ progenitor cells and cells of the mononuclear phagocyte system. Reactivation from latency is common during states of immunosuppression, such as in recipients of solid organ transplants or individuals with HIV/AIDS. Congenital transmission occurs via the placenta during maternal viremia.

Clinical manifestations

In immunocompetent hosts, primary infection is often asymptomatic but can present as a mononucleosis-like illness. Severe disease is primarily observed in immunocompromised patients, manifesting as retinitis, esophagitis, colitis, pneumonitis, and encephalitis. Congenital infection can result in sensorineural hearing loss, chorioretinitis, intellectual disability, and hepatosplenomegaly, collectively known as cytomegalic inclusion disease. Complications in hematopoietic stem cell transplant recipients are a major focus of clinical research at centers like the Fred Hutchinson Cancer Research Center.

Diagnosis

Diagnosis relies on detecting the virus, its components, or the host's immune response. Methods include viral culture from clinical specimens, detection of viral antigens (pp65 antigenemia assay), and amplification of viral DNA via polymerase chain reaction from blood, cerebrospinal fluid, or tissue. Serological tests to detect IgM and IgG antibodies, such as those developed by Abbott Laboratories and Roche Diagnostics, are used to determine infection status. Histopathological examination of tissue biopsies may reveal characteristic "owl's eye" intranuclear inclusions.

Treatment and prevention

First-line antiviral therapy involves ganciclovir and its oral prodrug valganciclovir, which inhibit viral DNA polymerase. Alternatives include foscarnet, cidofovir, and the recently approved letermovir, which targets the terminase complex. Prophylaxis or preemptive therapy is standard in high-risk transplant patients managed according to protocols from organizations like the American Society of Transplantation. Prevention strategies include screening of blood and organ donors, use of cytomegalovirus-immune globulin, and development of vaccines, with research efforts led by entities such as the National Institute of Allergy and Infectious Diseases.

Epidemiology

Cytomegalovirus is distributed worldwide, with seroprevalence increasing with age and varying by geographic region and socioeconomic status. In developed countries like the United States and the United Kingdom, approximately 50-60% of adults are seropositive, whereas in developing regions and among lower socioeconomic groups, seroprevalence can exceed 90% by adulthood. It is a leading cause of congenital infection, affecting an estimated 0.5-1% of all live births globally. The virus remains a major cause of morbidity and mortality in patients with AIDS and transplant recipients, underscoring its global health burden as monitored by the World Health Organization.

Category:Herpesviruses Category:Infectious diseases